• OPEN AN ACCOUNT
Indian Indices
Sensex
74,459.53 308.49
( 0.42%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,176.05 -1,483.42
(-2.29%)
Nikkei 225
10,722.51 0.44
(0.00%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
0.9409652
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
26.33
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

A B Infrabuild standalone net profit declines 11.29% in the March 2026 quarter
May 29,2026
Net profit of A B Infrabuild declined 11.29% to Rs 5.97 crore in the quarter ended March 2026 as against Rs 6.73 crore during the previous quarter ended March 2025. Sales rose 16.98% to Rs 83.93 crore in the quarter ended March 2026 as against Rs 71.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 19.98% to Rs 19.34 crore in the year ended March 2026 as against Rs 16.12 crore during the previous year ended March 2025. Sales rose 23.08% to Rs 256.21 crore in the year ended March 2026 as against Rs 208.17 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales83.9371.75 17 256.21208.17 23
OPM %14.4217.49 -14.8615.87 -
PBDT9.5210.75 -11 31.2427.93 12
PBT8.149.31 -13 26.2622.52 17
NP5.976.73 -11 19.3416.12 20